BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 26160324)

  • 1. Aggravated restenosis and atherogenesis in ApoCIII transgenic mice but lack of protection in ApoCIII knockouts: the effect of authentic triglyceride-rich lipoproteins with and without ApoCIII.
    Li H; Han Y; Qi R; Wang Y; Zhang X; Yu M; Tang Y; Wang M; Shu YN; Huang W; Liu X; Rodrigues B; Han M; Liu G
    Cardiovasc Res; 2015 Sep; 107(4):579-89. PubMed ID: 26160324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased inflammation, endoplasmic reticulum stress and oxidative stress in endothelial and macrophage cells exacerbate atherosclerosis in ApoCIII transgenic mice.
    Yingchun H; Yahong M; Jiangping W; Xiaokui H; Xiaohong Z
    Lipids Health Dis; 2018 Sep; 17(1):220. PubMed ID: 30223835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postprandial lipoproteins and the molecular regulation of vascular homeostasis.
    Botham KM; Wheeler-Jones CP
    Prog Lipid Res; 2013 Oct; 52(4):446-64. PubMed ID: 23774609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toll-like receptor 2 mediates apolipoprotein CIII-induced monocyte activation.
    Kawakami A; Osaka M; Aikawa M; Uematsu S; Akira S; Libby P; Shimokado K; Sacks FM; Yoshida M
    Circ Res; 2008 Dec; 103(12):1402-9. PubMed ID: 18974386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein CIII in apolipoprotein B lipoproteins enhances the adhesion of human monocytic cells to endothelial cells.
    Kawakami A; Aikawa M; Libby P; Alcaide P; Luscinskas FW; Sacks FM
    Circulation; 2006 Feb; 113(5):691-700. PubMed ID: 16461842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein CIII Deficiency Protects Against Atherosclerosis in Knockout Rabbits.
    Yan H; Niimi M; Matsuhisa F; Zhou H; Kitajima S; Chen Y; Wang C; Yang X; Yao J; Yang D; Zhang J; Murakami M; Nakajima K; Wang Y; Liu E; Liang J; Chen YE; Fan J
    Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):2095-2107. PubMed ID: 32757647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced high density lipoprotein cholesterol in severe hypertriglyceridemic ApoCIII transgenic mice via lowered hepatic ApoAI synthesis.
    Han Y; Qi R; Liu G
    Biochem Biophys Res Commun; 2015 Jul; 462(4):420-5. PubMed ID: 25969427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of diet on occlusive coronary artery atherosclerosis and myocardial infarction in scavenger receptor class B, type 1/low-density lipoprotein receptor double knockout mice.
    Fuller M; Dadoo O; Serkis V; Abutouk D; MacDonald M; Dhingani N; Macri J; Igdoura SA; Trigatti BL
    Arterioscler Thromb Vasc Biol; 2014 Nov; 34(11):2394-403. PubMed ID: 25212235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein CIII may mediate the impacts of angiopoietin-like protein 8 on triglyceride metabolism.
    Luo M; Su X; Yi Y; Yang Y; Peng D
    Lipids Health Dis; 2018 Jul; 17(1):160. PubMed ID: 30021607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statins suppress apolipoprotein CIII-induced vascular endothelial cell activation and monocyte adhesion.
    Zheng C; Azcutia V; Aikawa E; Figueiredo JL; Croce K; Sonoki H; Sacks FM; Luscinskas FW; Aikawa M
    Eur Heart J; 2013 Feb; 34(8):615-24. PubMed ID: 22927557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of apolipoprotein CIII in triglyceride-rich lipoprotein metabolism.
    Fredenrich A
    Diabetes Metab; 1998 Dec; 24(6):490-5. PubMed ID: 9932215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triglyceride-rich lipoproteins prime aortic endothelium for an enhanced inflammatory response to tumor necrosis factor-alpha.
    Ting HJ; Stice JP; Schaff UY; Hui DY; Rutledge JC; Knowlton AA; Passerini AG; Simon SI
    Circ Res; 2007 Feb; 100(3):381-90. PubMed ID: 17234968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ABCA1 promotes the de novo biogenesis of apolipoprotein CIII-containing HDL particles in vivo and modulates the severity of apolipoprotein CIII-induced hypertriglyceridemia.
    Kypreos KE
    Biochemistry; 2008 Sep; 47(39):10491-502. PubMed ID: 18767813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chylomicronemia due to apolipoprotein CIII overexpression in apolipoprotein E-null mice. Apolipoprotein CIII-induced hypertriglyceridemia is not mediated by effects on apolipoprotein E.
    Ebara T; Ramakrishnan R; Steiner G; Shachter NS
    J Clin Invest; 1997 Jun; 99(11):2672-81. PubMed ID: 9169497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ApoCIII as a Cardiovascular Risk Factor and Modulation by the Novel Lipid-Lowering Agent Volanesorsen.
    Rocha NA; East C; Zhang J; McCullough PA
    Curr Atheroscler Rep; 2017 Nov; 19(12):62. PubMed ID: 29124482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the combination of methyltestosterone and esterified estrogens compared with esterified estrogens alone on apolipoprotein CIII and other apolipoproteins in very low density, low density, and high density lipoproteins in surgically postmenopausal women.
    Chiuve SE; Martin LA; Campos H; Sacks FM
    J Clin Endocrinol Metab; 2004 May; 89(5):2207-13. PubMed ID: 15126543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic Overexpression of Soluble Urokinase Receptor (uPAR) Suppresses Diet-Induced Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient (LDLR-/-) Mice.
    Larmann J; Jurk K; Janssen H; Müller M; Herzog C; Lorenz A; Schmitz M; Nofer JR; Theilmeier G
    PLoS One; 2015; 10(8):e0131854. PubMed ID: 26313756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No effect of C-reactive protein on early atherosclerosis in LDLR-/- / human C-reactive protein transgenic mice.
    Torzewski M; Reifenberg K; Cheng F; Wiese E; Küpper I; Crain J; Lackner KJ; Bhakdi S
    Thromb Haemost; 2008 Jan; 99(1):196-201. PubMed ID: 18217154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In the absence of the low density lipoprotein receptor, human apolipoprotein C1 overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway.
    Jong MC; Dahlmans VE; van Gorp PJ; van Dijk KW; Breuer ML; Hofker MH; Havekes LM
    J Clin Invest; 1996 Nov; 98(10):2259-67. PubMed ID: 8941642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ApoCIII: A multifaceted protein in cardiometabolic disease.
    D'Erasmo L; Di Costanzo A; Gallo A; Bruckert E; Arca M
    Metabolism; 2020 Dec; 113():154395. PubMed ID: 33058850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.